NCT02458352View on ClinicalTrials.gov

Ultra Low Dose CT for CACS and AC of SPECT

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Coronary Artery Disease
Interventions
DEVICE

Ultra low dose non-contrast enhanced CT

Non-contrast enhanced CT for CACS and AC using a novel protocol for ultra low dose radiation dose exposure

DEVICE

Standard dose non-contrast enhanced CT

Clinically indicated non-contrast enhanced CT for CACS and AC according to routine protocol

Trial Locations (1)

8091

Department of Nuclear Medicine, University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT02458352 - Ultra Low Dose CT for CACS and AC of SPECT | Biotech Hunter | Biotech Hunter